Hypothyroid Patients Encoding Combined MCT10 and DIO2 Gene Polymorphisms May Prefer L-T3 + L-T4 Combination Treatment – Data Using a Blind, Randomized, Clinical Study

Conclusion: The present study indicates that the combination of polymorphisms inDIO2 (rs225014) andMCT10 (rs17606253) enhances hypothyroid patients ’ preference for L-T4 + L-T3 replacement therapy. In the future, combination therapy may be restricted or may be even recommended to individuals harbouring certain polymorphisms.Eur Thyroid J
Source: European Thyroid Journal - Category: Endocrinology Source Type: research